RecruitingNCT03601702
EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke
Multicentric Observational Prospective Study on the Use of the EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke
Sponsor
Niguarda Hospital
Enrollment
100 participants
Start Date
Jan 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The primary aim of Registrap study is to assess the safety and effectiveness of the EmboTrap®II Clot Retriever device (Neuravi) in patients with acute ischemic stroke from large vessel occlusion.
Eligibility
Min Age: 18 Years
Inclusion Criteria6
- Signed Informed Consent Form
- Large Vessel Occlusion on CTA or MRA in the Anterior or Posterior Proximal Cerebral Vasculature up to A1, M1, Dominant M2, P1
- ASPECTS ≥ 6
- Mismatch or good collaterals showed at MR or multiphasic CTA or pCT
- Groin Puncture performed within 12 hours from symptom onset
- Use of EmboTrap® II Revascularization Device (Neuravi) as the first or second line treatment
Exclusion Criteria2
- Informed consent not given
- Extracranial or tandem occlusion
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEMechanical thrombectomy with EmboTrap ® II Device
Endovascular treatment with mechanical thrombectomy using EmboTrap ® II Device (Neuravi)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03601702
Related Trials
OPtimizing REperfusion by Intra-Arterial ThRomboLysis as Adjunct to Endovascular Treatment for Medium Vessel Occlusion
NCT071378321 location
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302218 locations
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
NCT0726330812 locations
Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke
NCT074048521 location
Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well
NCT071159406 locations